These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4607883)

  • 21. A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer.
    Trudeau M; Zukiwski A; Langleben A; Boos G; Batist G
    Cancer Chemother Pharmacol; 1995; 35(6):496-500. PubMed ID: 7882458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer].
    Bonadonna G; Monfardini S; Oldini C; Guzzon A; Di Pietro S
    Tumori; 1969; 55(5):277-89. PubMed ID: 4909863
    [No Abstract]   [Full Text] [Related]  

  • 23. Cis-platinum plus high-dose methotrexate. Toxicity and efficacy in ovarian carcinoma.
    Talley R; Boutseleis J; Neidhart JA
    Am J Clin Oncol; 1983 Jun; 6(3):369-74. PubMed ID: 6682623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
    Lippman AJ; Helson C; Helson L; Krakoff IH
    Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381
    [No Abstract]   [Full Text] [Related]  

  • 25. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.
    Wittes R; Heller K; Randolph V; Howard J; Vallejo A; Farr H; Harrold C; Gerold F; Shah J; Spiro R; Strong E
    Cancer Treat Rep; 1979; 63(9-10):1533-8. PubMed ID: 498153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck.
    Kish JA; Weaver A; Jacobs J; Cummings G; Al-Sarraf M
    Cancer; 1984 May; 53(9):1819-24. PubMed ID: 6538456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
    Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
    J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma.
    Kardinal CG; Luce JK
    Cancer Treat Rep; 1977 Dec; 61(9):1691-3. PubMed ID: 413624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
    Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 33. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
    Samson MK; Baker LH; Devos JM; Buroker TR; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1976 Jan; 60(1):91-7. PubMed ID: 63332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 37. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
    Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
    J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
    Schilsky RL; O'Laughlin K; Ratain MJ
    Cancer Res; 1986 Aug; 46(8):4184-8. PubMed ID: 3731086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
    Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
    Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.